Transfection of constitutively active mitogen-activated protein/extracellular signal-regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells

Cancer Research

Volumn 60, Issue 6, 2000, Pages 1552-1556

  Welch, Danny R ^a   Sakamaki, Toshiyuki ^a   Pioquinto, Ralph ^b   Leonard, Timothy O ^a   Goldberg, Steven F ^a   Hon, Qiufang ^c   Erikson, Raymond L ^c   Rieber, Manuel ^d   Rieber, Mary Strasberg ^d   Hicks, Deana J ^a   Bonventre, Joseph V ^b   Alessandrini, Alessandro ^b  

^a PENN STATE CANCER INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL TRANSFORMATION; ENZYME ACTIVATION; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; CELL ADHESION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CLONE CELLS; FEMALE; LUNG NEOPLASMS; MAP KINASE KINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; PROTEIN-SERINE-THREONINE KINASES; TRANSFECTION;

EID: 0034654639     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Campbell, S. L., Khosravi-Far, R., Rossman, K. L., Clark, G. J., and Der, C. J. Increasing complexity of Ras signaling. Oncogene, 17: 1395-1413, 1998.
2. Chambers, A. F., and Tuck, A. B. Ras-responsive genes and tumor metastasis. Crit. Rev. Oncog., 4: 95-114, 1993.
3. Alessandrini, A., Greulich, H., Huang, W., and Erikson, R. L. Mek1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells. J. Biol. Chem., 271: 31612-31618, 1996.
4. Webb, C. P., Van Aelst, L., Wigler, M. H., and Vande, W. G. Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc. Natl. Acad. Sci. USA, 95: 8773-8778, 1998.
5. Welch, D. R. Technical considerations for studying cancer metastasis in vivo. Clin. Exp. Metastasis, 15: 272-306, 1997.
6. Rieber, M., Welch, D. R., and Strasberg-Rieber, M. Differential gene expression associated with suppression of metastatic melanoma cell spreading and proliferation on adhesion-restrictive substrates. Proc. Am. Assoc. Cancer Res., 40: 491, 1999.
7. Lee, J-H., and Welch, D. R. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res., 57: 2384-2387, 1997.
8. Nicolson, G. L., Lembo, T. M., and Welch, D. R. Growth of rat mammary adenocarcinoma cells in semisolid clonogenic medium not correlated with spontaneous metastatic behavior: heterogeneity in the metastatic, antigenic, enzymatic and drug sensitivity properties of cells from different sized colonies. Cancer Res., 48: 399-404, 1988.
9. Chambers, A. F., and Matrisian, L. M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst., 89: 1260-1270, 1997.
10. Welch, D. R., and Wei, L. L. Genetic and epigenetic regulation of human breast cancer progression and metastasis. Endocr. Relat. Cancer, 5: 155-197, 1998.
11. Ghiso, J. A., Alonso, D. F., Farias, E. F., Gomez, D. E., and Kier Joffe, E. B. Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. Eur. J. Biochem., 263: 295-304, 1999.
12. McCawley, L. J., Li, S., Wattenberg, E. V., and Hudson, L. G. Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J. Biol. Chem., 274: 4347-4353, 1999.
13. Chambers, A. F., Colella, R., Denhardt, D. T., and Wilson, S. M. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells. Mol. Carcinog., 5: 238-245, 1992.
14. Frade, R., Rodrigues-Lima, F., Huang, S. Y., Xie, K. P., Guillaume, N., and Bar-Eli, M. Procathepsin-L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells. Cancer Res., 58: 2733-2736, 1998.